Media Coverage header image

Media Coverage

Advanced Search
  • 01212020
    USA Today Online

    From makeup and oils to capsules for stress relief, cannabis-based goods are flowing into the marketplace. But while they may not get you high, they can still cause you problems at work. Cannabidiol or CBD has been showing up in a widening array of goods. That's because federal legislation in 2018 deemed that hemp - one of its sources - was not an illegal controlled substance.

  • 01212020
    SHRM Online

    Employers must provide a safe work environment, and they want to ensure their employees are productive, but is maintaining a drug-testing program in furtherance of these goals worth the hassle? The answer may depend on the workplace.[CR-LF][CR-LF]"You have to consider the needs of the business, in addition to any applicable state laws," said Anne-Marie Welch, an attorney with Clark Hill in Birmingham, Mich. Some employers are federal contractors or hire drivers and have to follow specific drug-free workplace laws. Other employers are struggling to find qualified employees or want to maintain a certain culture and think that drug testing—particularly for marijuana—will hinder their ability to attract and retain talent.

  • 01172020
    MedTech Dive

    LabCorp and Quest went into 2019 predicting some upsides to the Protecting Access to Medicare Act​ (PAMA), which is driving down how much Medicare pays for tests. The clinical laboratory leaders objected to the price cuts but felt they were better equipped to cope with them than smaller rivals, creating opportunities to consolidate the market.[CR-LF][CR-LF]However, the anticipated surge in acquisitions of local and hospital laboratories never materialized. Adam Schechter, who took over as CEO of LabCorp in November, discussed some reasons for lack of M&A activity during a presentation at the J.P. Morgan Healthcare Conference Tuesday.

  • 01102020
    Chicago Tribune Online

    Now that recreational pot is legal in Illinois, marijuana enthusiasts may feel like it’s finally time to emerge from hiding.[CR-LF][CR-LF]But people with jobs — or looking for them — might want to stay in the shadows for now as companies figure out how to handle employees who partake.

  • 01092020
    Bloomberg Law

    Medical companies that develop tests to diagnose neurological disorders, heart disease risk and fetal abnormalities have been in legal limbo since a 2012 Supreme Court ruling that limited the patenting of such tests, finding they occurred in nature and were not invented.[CR-LF][CR-LF]The high court may signal as soon as Friday whether it will revisit the subject as such tests become critical to the burgeoning field of personalized medicine, in which doctors determine whether a patient is genetically susceptible to a particular disease or would respond to certain treatments.

Show 5102550100 per page